Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Migraine is a common neurological disorder often treated with triptans. Triptan overuse can lead to increased frequency of headache in some patients, a phenomenon termed medication overuse headache. Previous preclinical studies have demonstrated that repeated or sustained triptan administration for several days can elicit persistent neural adaptations in trigeminal ganglion cells innervating the dura, prominently characterized by increased labelling of neuronal profiles for calcitonin gene related peptide. Additionally, triptan administration elicited a behavioural syndrome of enhanced sensitivity to surrogate triggers of migraine that was maintained for weeks following discontinuation of drug, a phenomenon termed 'triptan-induced latent sensitization'. Here, we demonstrate that triptan administration elicits a long-lasting increase in identified rat trigeminal dural afferents labelled for neuronal nitric oxide synthase in the trigeminal ganglion. Cutaneous allodynia observed during the period of triptan administration was reversed by NXN-323, a selective inhibitor of neuronal nitric oxide synthase. Additionally, neuronal nitric oxide synthase inhibition prevented environmental stress-induced hypersensitivity in the post-triptan administration period. Co-administration of NXN-323 with sumatriptan over several days prevented the expression of allodynia and enhanced sensitivity to stress observed following latent sensitization, but not the triptan-induced increased labelling of neuronal nitric oxide synthase in dural afferents. Triptan administration thus promotes increased expression of neuronal nitric oxide synthase in dural afferents, which is critical for enhanced sensitivity to environmental stress. These data provide a biological basis for increased frequency of headache following triptans and highlight the potential clinical utility of neuronal nitric oxide synthase inhibition in preventing or treating medication overuse headache.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909 · cited 2×
“The International Headache Society defines medication overuse headache as more than 15 headaches per month, during regular overuse (415 days per month) of acute analgesics or symptomatic drugs for 43 months and specifies triptan-induced medication overuse headache as occurring with the intake of at least 10 doses of t…”
BackgroundSelf-citationThe Triggers or Precipitants of the Acute Migraine Attack
Kelman, L. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01303.x · Cited by 871
Silberstein, S., Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., et al. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00878.x · Cited by 517 · cited 2×
“The International Headache Society defines medication overuse headache as more than 15 headaches per month, during regular overuse (415 days per month) of acute analgesics or symptomatic drugs for 43 months and specifies triptan-induced medication overuse headache as occurring with the intake of at least 10 doses of t…”
BackgroundSelf-citationMedication-overuse headache: a worldwide problem
Diener, H.-C., & Limmroth, V. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00824-5 · Cited by 455
Van der Schueren, B. J., Lunnon, M. W., Laurijssens, B. E., Guillard, F., Palmer, J., Van Hecken, A., Depré, M., Vanmolkot, F. H., & de Hoon, J. N. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008329548 · Cited by 39
Cited by
Iyengar, S., Ossipov, M. H., & Johnson, K. W. (2017) · Pain · doi:10.1097/j.pain.0000000000000831 · Cited by 584
Self-citationDodick, D. W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30478-1 · Cited by 557
Self-citationCGRP and the Trigeminal System in Migraine
Iyengar, S., Johnson, K. W., Ossipov, M. H., & Aurora, S. K. (2019) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13529 · Cited by 486
Self-citationNeurogenic inflammation and its role in migraine
Ramachandran, R. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0676-y · Cited by 310
Cutaneous allodynia as a predictor of migraine chronification
Louter, M. A., Bosker, J. E., van Oosterhout, W. P. J., van Zwet, E. W., Zitman, F. G., Ferrari, M. D., & Terwindt, G. M. (2013) · Brain · doi:10.1093/brain/awt251 · Cited by 278
Constitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence
Corder, G., Doolen, S., Donahue, R. R., Winter, M. K., Jutras, B. L., He, Y., Hu, X., Wieskopf, J. S., Mogil, J. S., Storm, D. R., et al. (2013) · Science · doi:10.1126/science.1239403 · Cited by 240
Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies
Meng, I. D., Dodick, D., Ossipov, M. H., & Porreca, F. (2011) · Cephalalgia · doi:10.1177/0333102411402367 · Cited by 70
Self-citationMigraine genetics: current findings and future lines of research
Persico, A. M., Verdecchia, M., Pinzone, V., & Guidetti, V. (2015) · neurogenetics · doi:10.1007/s10048-014-0433-x · Cited by 25
Metadata
- Authors
- De Felice, M., Ossipov, M. H., Wang, R., Dussor, G., Lai, J., Meng, I. D., Chichorro, J., Andrews, J. S., Rakhit, S., Maddaford, S., Dodick, D., & Porreca, F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-13
- Volume
- 133
- Issue
- 8
- Pages
- 2475-2488
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2163386604
- Cited by
- 126
- References
- 5
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.